FIELD: veterinary medicine.
SUBSTANCE: liquid homogeneous phase for transdermal pharmaceutical compositions is described that provides absorption of physiologically active substances through the animal skin in the absence of irritant effect, has anti-mucus properties and has a pH value in the range of 4 to 6. The phase consists of a low-viscosity mixture of ether and amide solvent and a high-viscosity mixture of penetrants. The phase can be used for delivery of local and systemic physiologically active agents to the mammalian organism.
EFFECT: convenience in storage and use under production conditions.
5 cl, 6 tbl, 38 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR REGULATION OF SEXUAL BEHAVIOR AND CONTRACEPTION OF FEMALE MAMMALS | 2015 |
|
RU2617518C2 |
| METHOD OF CONTROLLING SEXUAL BEHAVIOUR OF MALE MAMMALS | 2015 |
|
RU2616252C2 |
| METHOD OF SYNTHESIS OF PEPTIDE DERIVATIVES OR THEIR PHYSIOLOGICALLY ACCEPTABLE SALTS | 1990 |
|
RU2047621C1 |
| TLR7 AGONISTS | 2019 |
|
RU2817014C2 |
| C-ARYL GLUCOSIDE DERIVATIVES, PREPARATION PROCESS AND PHARMACEUTICAL USE THEREOF | 2011 |
|
RU2606501C2 |
| IMMUNOMODULATORY AZALIDES BASED ON UREA | 2021 |
|
RU2811591C1 |
| COMPOUNDS - SULFAMATE DERIVATIVES FOR USE IN TREATING OR RELIEVING PAIN | 2014 |
|
RU2699025C1 |
| HESPERIDINE CONJUGATE AND METHOD FOR PREPARATION THEREOF | 2020 |
|
RU2742030C1 |
| METHOD OF TREATMENT OF DISEASES AT MAMMALS | 2004 |
|
RU2344121C2 |
| METHOD OF INHIBITION OF RETROVIRAL PROTEASES ACTIVITY | 1991 |
|
RU2028155C1 |
